Murat Bardakçı

8PUBLICATIONS
26CO-AUTHORS
Predictive and prognostic markersMedical biotechnology not elsewhere classifiedMedical mycologyTumour immunologyModels of care and place of birth
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 16, 2026
Low muscle mass predicts poor response to neoadjuvant chemotherapy in advanced ovarian cancer.

|Nov 27, 2025
Correction: Kalkan et al. Efficacy of Immunotherapy Versus Chemotherapy in Advanced Pleural Mesothelioma: A Turkish Oncology Group (TOG) Study. Medicina 2025, 61, 638.

Ziya Kalkan, Senar Ebinc, Murat Arcagok

|Aug 28, 2025
Anorectal Malignant Melanoma: Diagnostic Pitfalls and Prognostic Insights from a Single-Center Retrospective Analysis.

Emre Hafızoğlu, Murat Bardakçı, Yakup Ergun

|Jun 27, 2025
"Pre-Treatment" and "Post-Treatment" Systemic Inflammatory Markers: Is There Any Prognostic Role for Metastatic Cervical Cancer on Bevacizumab Containing Treatment?

Serkan Yaşar, Ahmet Kadıoğlu, Arif Akyildiz

|Apr 26, 2025
Prognostic Factors and Long-Term Survival in Kaposi's Sarcoma Patients: Results from a 28-Year Retrospective Cohort.

Emre Hafızoğlu, Murat Bardakçı, Yakup Ergun

|Apr 26, 2025
Efficacy of Immunotherapy Versus Chemotherapy in Advanced Pleural Mesothelioma: A Turkish Oncology Group (TOG) Study.

Ziya Kalkan, Senar Ebinc, Murat Arcagok

Pageof 2

Frequent Collaborators

4 joint publications

Öznur Bal

3 joint publications

Emre Hafızoğlu

3 joint publications

Fahriye Tuğba Köş

3 joint publications

Doğan Uncu